Medication info
Baro-Ejet Tablet 1/10 mg (Pitavastatin Calcium Hydrate, Ezetimibe)

Baro-Ejet Tablet 1/10 mg (Pitavastatin Calcium Hydrate, Ezetimibe)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›1.102mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewong Pharmaceutical Co., Ltd.
Appearance
Pale green round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202600266 · Approved 2026.01.29

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer 1/10 mg once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Ingredients

Manufacturer
Daewong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication helps reduce elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It also increases levels of HDL cholesterol, the good cholesterol, supporting cardiovascular health. This medication is used as an adjunct to diet and effectively improves blood lipid levels to enhance health.

How to take

Adult dose

Administer 1/10 mg once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Precautions

This medication should not be used in patients with known allergies or a history of hypersensitivity to any of the components. Patients with active liver disease or who have persistently elevated liver enzyme levels without an identified cause should not take this medication. It is also not safe for patients with severe liver impairment, biliary obstruction, or cholestasis. Patients taking ciclosporin should not use this medication. It is contraindicated in patients with myopathy or suspected myopathy. Women who are pregnant or may become pregnant, as well as nursing mothers, should avoid this medication. Its safety and efficacy in children have not been established, thus it should not be used in this population. Patients with lactose intolerance or certain genetic lactose metabolic disorders should also refrain from using this medication. Patients with mild to moderate liver impairment or a history of liver disease should use this medication with caution. Caution is also advised for patients who consume alcohol excessively. Patients with renal impairment or those taking fibrate drugs or niacin should be cautious, as there is a risk of rhabdomyolysis and worsening renal function. Patients with hypothyroidism, those with genetic muscle disorders, or a history of drug-induced muscle injury should be administered this medication with care. Elderly patients may be at a higher risk for side effects, so caution is warranted. Patients with severe myasthenia gravis or ocular myasthenia should also exercise caution when using this medication. This medication may cause various adverse reactions such as muscle pain, abdominal pain, rash, and itching, particularly muscle-related adverse reactions like rhabdomyolysis or myopathy; immediate consultation with a doctor is recommended if muscle pain or weakness occurs. Liver function abnormalities may also present, requiring regular liver function tests. Rarely, thrombocytopenia or hypersensitivity reactions may occur. Neurological symptoms may include drowsiness, insomnia, and headache. Gastrointestinal symptoms such as nausea, vomiting, and diarrhea have been reported. This medication is used for the treatment of hypercholesterolemia, and it is important to confirm the diagnosis of hypercholesterolemia through adequate testing before administration. Non-drug therapies such as dietary regulation and exercise should be undertaken, and the treatment can be discontinued if no therapeutic effect is observed. Due to the risk of myopathy and rhabdomyolysis, it is advisable to perform a creatine phosphokinase test before administration, and if symptoms such as muscle pain, tenderness, or weakness occur, treatment should be stopped immediately, and medical advice should be sought. Liver function tests should be performed regularly before and during treatment to check if liver enzyme levels are elevated. Rare respiratory adverse effects such as interstitial lung disease may also occur, hence consulting a doctor if symptoms like shortness of breath or coughing are present. This medication may increase the risk of diabetes, but due to its greater preventive effect against vascular disease, it is recommended not to discontinue treatment. There may be drug interactions, so it is essential to inform the doctor if taking other drugs, particularly ciclosporin, fibrate medications, niacin, or anticoagulants, and to closely observe symptoms and blood test results during treatment with this medication. Pregnant women, those who may become pregnant, and nursing mothers should not take this medication, and if taken during pregnancy, it should be stopped immediately, and a doctor consulted. Its safety and efficacy in children have not been proven, thus it is not used in this group. Elderly patients may experience adverse reactions due to decreased physiological function, so dosage adjustments may be necessary if symptoms arise. Patients with renal impairment should also be careful with treatment, closely monitoring for muscle symptoms due to the risk of rhabdomyolysis. In case of overdose, there is no specific antidote, so symptomatic treatment and supportive care should be implemented, monitoring liver function tests and serum creatine phosphokinase levels.

Side effects

Syndrome of hyperactivity, rash, abdominal pain, chest pain, muscle pain, subjective symptom adverse reactions (abdominal pain, rash, malaise, paralysis, itching), increased γ-GT, elevated plasma creatine phosphokinase levels, increased serum ALT, increased serum AST, headache, muscle pain, weakness, jaundice, thrombocytopenia, urticaria, erythema, angioedema, increased bilirubin, increased cholinesterase, stiff feeling, drowsiness, insomnia, feeling of heaviness in the head, dizziness, thirst, indigestion, abdominal bloating, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, decreased granulocytes, leukopenia, increased eosinophils, leukocytosis, increased globulin, positive Coombs test, anemia, polyuria, increased BUN, elevated serum creatinine, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, muscle cramps, increased myoglobin, increased CPK, palpitations, fatigue, skin pain, burning sensation, joint pain, edema, blurred vision, photophobia, hearing loss, hematuria, increased uric acid levels, elevated serum potassium and phosphorus, taste disturbance, colored urine, malaise, positive antinuclear antibody test, hair loss, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, myasthenia gravis, ocular myasthenia, facial edema, edema, arm swelling, hypersensitivity, headache, dizziness, skin tingling, insomnia, sleep disorders, loss of appetite, increased blood pressure, chest discomfort, weakness, abdominal pain, indigestion, thirst, constipation, nausea, increased γ-GT, elevated LDH, increased ALP, itching, urticaria, thrombocytopenia, increased blood creatinine, elevated BUN, fatigue, chest pain, chest discomfort, systemic edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, dry mouth, discomfort in the epigastrium, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, joint pain, hypoglycemia, anemia, splenomegaly, sweating, conjunctival congestion, renal failure, hepatic dysfunction, increased blood pressure, increased blood urea, abnormal liver function tests, anaphylaxis, erythema multiforme, pancreatitis, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, increased eosinophils, drug reaction accompanied by systemic symptoms, severe skin adverse reactions, drug-induced hepatic injury

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture exposure. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This ensures the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Pale green round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.